MedTrace Logo

Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia

NCT03188900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2026-03-27

No results posted yet for this study

Summary

The aim of the study is to setup a collection of maternal plasma and serum from patients with preeclampsia and normal pregnancy for in vitro validation of new therapeutics based on extra-corporal removal of sFlt-1

Conditions

Interventions

BIOLOGICAL

A collection of maternal plasma and serum

A collection of maternal plasma and serum from patients with preeclampsia (PE) and normal pregnancy (NP)

Sponsors & Collaborators

  • INSERM UMR-S 1139

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Edouard Lecarpentier, MD, PhD · Centre Hospitalier intercommunal de Créteil

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-12
Primary Completion
2019-06-12
Completion
2019-06-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03188900 on ClinicalTrials.gov